These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23563356)

  • 1. No mutations in the serotonin related TPH1 and HTR1B genes in patients with monogenic sclerosing bone disorders.
    Boudin E; Jennes K; de Freitas F; Tegay D; Mortier G; Van Hul W
    Bone; 2013 Jul; 55(1):52-6. PubMed ID: 23563356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lrp5 and bone formation : A serotonin-dependent pathway.
    Yadav VK; Ducy P
    Ann N Y Acad Sci; 2010 Mar; 1192():103-9. PubMed ID: 20392224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.
    Yadav VK; Ryu JH; Suda N; Tanaka KF; Gingrich JA; Schütz G; Glorieux FH; Chiang CY; Zajac JD; Insogna KL; Mann JJ; Hen R; Ducy P; Karsenty G
    Cell; 2008 Nov; 135(5):825-37. PubMed ID: 19041748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
    Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
    BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
    Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
    J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in sFRP1 or sFRP4 are not a common cause of craniotubular hyperostosis.
    Boudin E; Piters E; Fijalkowski I; Stevenheydens G; Steenackers E; Kuismin O; Moilanen JS; Mortier G; Van Hul W
    Bone; 2013 Jan; 52(1):292-5. PubMed ID: 23044044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of Lrp5 function in osteoblast progenitors.
    Yadav VK; Arantes HP; Barros ER; Lazaretti-Castro M; Ducy P
    Calcif Tissue Int; 2010 May; 86(5):382-8. PubMed ID: 20333369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of serotonin inhibition in mouse models of bone loss.
    Inose H; Zhou B; Yadav VK; Guo XE; Karsenty G; Ducy P
    J Bone Miner Res; 2011 Sep; 26(9):2002-11. PubMed ID: 21608033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5.
    Yorgan TA; Peters S; Jeschke A; Benisch P; Jakob F; Amling M; Schinke T
    J Bone Miner Res; 2015 Jul; 30(7):1175-83. PubMed ID: 25640331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit/hyperactivity disorder symptoms in offspring of mothers with impaired serotonin production.
    Halmøy A; Johansson S; Winge I; McKinney JA; Knappskog PM; Haavik J
    Arch Gen Psychiatry; 2010 Oct; 67(10):1033-43. PubMed ID: 20921119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Wnt-beta-catenin signaling in bone metabolism].
    Urano T
    Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases.
    Gregson CL; Wheeler L; Hardcastle SA; Appleton LH; Addison KA; Brugmans M; Clark GR; Ward KA; Paggiosi M; Stone M; Thomas J; Agarwal R; Poole KE; McCloskey E; Fraser WD; Williams E; Bullock AN; Davey Smith G; Brown MA; Tobias JH; Duncan EL
    J Bone Miner Res; 2016 Mar; 31(3):640-9. PubMed ID: 26348019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin.
    Frost M; Andersen TE; Yadav V; Brixen K; Karsenty G; Kassem M
    J Bone Miner Res; 2010 Mar; 25(3):673-5. PubMed ID: 20200960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin and pulmonary hypertension--from bench to bedside?
    MacLean MR; Dempsie Y
    Curr Opin Pharmacol; 2009 Jun; 9(3):281-6. PubMed ID: 19286424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism screening and haplotype analysis of the tryptophan hydroxylase gene (TPH1) and association with bipolar affective disorder in Taiwan.
    Lai TJ; Wu CY; Tsai HW; Lin YM; Sun HS
    BMC Med Genet; 2005 Mar; 6():14. PubMed ID: 15799788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tryptophan hydroxlyase 1 reporter that directs Cre recombinase extinguishable placental alkaline phosphatase expression in serotonergic (5-HT) neurons and peripheral tissues.
    Huynh ML; Rivkin E; Mui R; Cordes SP
    Genesis; 2011 Nov; 49(11):851-61. PubMed ID: 21438125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation.
    Haÿ E; Buczkowski T; Marty C; Da Nascimento S; Sonnet P; Marie PJ
    J Bone Miner Res; 2012 Sep; 27(9):1852-63. PubMed ID: 22576936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5.
    Lee GS; Simpson C; Sun BH; Yao C; Foer D; Sullivan B; Matthes S; Alenina N; Belsky J; Bader M; Insogna KL
    J Bone Miner Res; 2014 Apr; 29(4):976-81. PubMed ID: 24038240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When the gut talks to bone.
    Long F
    Cell; 2008 Nov; 135(5):795-6. PubMed ID: 19041744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
    Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
    Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.